Erythropoietin protects severe haemorrhagic shock-induced organ damage in conscious rats

Injury

Volumn 41, Issue 7, 2010, Pages 724-730

  Wu, Wen Tien ^a,b   Lin, Nien Tsung ^a   Subeq, Yi Maun ^a   Lee, Ru Ping ^a   Chen, Ing Ho ^a,b   Hsu, Bang Gee ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Erythropoietin; Haemorrhagic shock; Inflammatory cytokines

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VOLUME; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; FEMORAL ARTERY; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC SHOCK; KIDNEY; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LUNG; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SURVIVAL RATE; TACHYCARDIA; UREA NITROGEN BLOOD LEVEL;

EID: 77957128977     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2009.12.006     Document Type: Article

References (42)

1. Abdelrahman M. Sharples EJ, McDonald MC, et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004;22:63-9.
2. Abraham E, Jesmok G, Tuder R, et al. Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 1995;23:1319-26.
3. Algin MC, Hacioglu A, Yaylak F, et al. The role of erythropoietin in hemorrhagic shock-induced liver and renal injury in rats. Adv Ther 2008;25:1353-74.
4. Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 2008;141:14-31.
5. Bahrami S, Yao YM, Leichtfried G, et al. Significance of TNF in hemorrhagerelated hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 1997;272:H2219-26.
6. Brundage SI, Zautke NA, Holcomb JB, et al. Interleukin-6 infusion blunts proinflammatory cytokine production without causing systematic toxicity in a swine model of uncontrolled hemorrhagic shock. J Trauma 2004;57:970-7.
7. Chen CH, Lee RP, Wu WT, et al. Fluvastatin attenuate endotoxin shock induced organ damage in conscious rats. Resuscitation 2007;74:166-74.
8. Childs EW, Wood JG, Smalley DM, et al. Leukocyte adherence and sequestration following hemorrhagic shock and total ischemia in rats. Shock 1999;11:248-52.
9. Deitch EA, Xu DZ, Franko L, et al. Evidence favoring the role of the gut as a cytokine generating organ in rats subjected to hemorrhagic shock. Shock 1994;1:141-6.
10. Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998;158:444-51.
11. Fliser D, Bahlmann FH. Erythropoietin and the endothelium - a promising link? Eur J Clin Invest 2008;38:457-61.
12. Guarini S, Altavilla D, Cainazzo MM, et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107:1189-94.
13. Guneli E, Cavdar Z, lslekel H, et al. Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol Med 2007;13:509-17.
14. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Crit Care 2004;8:373-81.
15. Ivatury RR, Simon RJ, Islam S, et al. A prospective randomized study of endpoints of resuscitation after major trauma: global oxygen transport indices versus organ-specific gastric mucosal pH. J Am Coll Surg 1996;183:145-54.
16. Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004;43:649-59.
17. Johnson DW, Forman C, Vesey DA. Novel renoprotective actions of erythropoietin: new uses for an old hormone. Nephrol 2006:11:306-12.
18. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006:60(6 Suppl.). S3-11.
19. Keel M, Trentz O. Pathophysiology of polytrauma. Injury 2005;36:691-709.
20. Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Selective modulation of the erythropoietic and tissue-protective effects of erythropoietin: time to reach the full therapeutic potential of erythropoietin. Biochim Biophys Acta 2007;1776:1-9.
21. Kumral A, Baskin H, Duman N, et al. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol Neonate 2003:84:325-9.
22. Lee CC, Chang IJ, Yen ZS, et al. Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock. Shock 2005:24:177-81.
23. Lee CC, Lee RP, Subeq YM, et al. Fluvastatin attenuates severe hemorrhagic shock-induced organ damage in rats. Resuscitation 2009;80:372-8.
24. Lee CJ, Subeq YM, Lee RP, et al. Low-dose propofol ameliorates hemorrhagic shock induced organ damage in conscious rats. Clin Exp Pharmacol Physiol 2008:35:766-74.
25. Li Y, Takemura G, Okada H, et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovas Res 2006;71:684-94.
26. Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol 2001:12(17 Suppl.):S15-9.
27. Luyer MD, Greve JW, Hadfoune M, et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005;202:1023-9.
28. Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med 1992;20:80-93.
29. Mok YY, Moore PK. Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflamm Res 2008;57:512-8.
30. Peng TC, Liao KW, Lai HL, et al. The physiological changes of cumulative hemorrhagic shock in conscious rats. J Biomed Sci 2006;13:385-94.
31. Rixen D, Siegel JH. Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care 2005;9:441-53.
32. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009;265:663-79.
33. Rossert J, Eckardt KUJ. Erythropoietin receptors: their role beyond erythropoiesis. Nephrol Dial Transplant 2005;20:1025-8.
34. Rushing GD, Britt LD. Reperfusion injury after hemorrhage: a collective review. Ann Surg 2008:247:929-37.
35. Schmeding M, Neumann UP, Boas-Knoop S, et al. Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur Surg Res 2007;39:189-97.
36. Senthil M, Watkins A, Barios D, et al. Intravenous injection of trauma-hemorrhagic shock mesenteric lymph causes lung injury that is dependent upon activation of the inducible nitric oxide synthase pathway. Ann Surg 2007;246:822-30.
37. Sharpies EJ, Thiemermann C, Yaqoob MM. Mechanisms of disease : cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat Clin Pract Nephrol 2005:1:87-97.
38. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003;198:971-5.
39. Watters JM, Tieu BH, Todd SR, et al. Fluid resuscitation increases inflammatory gene transcription after traumatic injury. J Trauma 2006;61:300-8.
40. Wu H, Dong G, Liu H, et al. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur J Pharmacol 2009;602:406-12.
41. Wu H, Ren B, Zhu J, et al. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur J Cardiothorac Surg 2006;29:902-7.
42. Xu DZ, Lu Q, Adams CA, et al. Trauma-hemorrhagic shock-induced up-regulation of endothelial cell adhesion molecules is blunted by mesenteric lymph duct ligation. Crit Care Med 2004;32:760-5.